European Commission Explains Impact Of EU Pharma Review On SMEs & Non-Profit Entities

 
• By Ian Schofield

The EU pharmaceutical revision package includes proposals that will have a direct impact on smaller firms, including a targeted regulatory and procedural support scheme.

big and small execs
Smaller firms will have their own benefits from the EU pharma review • Source: Shutterstock

More from Europe

More from Geography